Shafran IH[au] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2020	2
2021	1
2022	1
2023	0

Page 1

Response to: 'Comment on 'Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab'' by Pethoe-Schramm et al.

Shafran IH, Alasti F, Smolen JS, Aletaha D. Shafran IH, et al. Ann Rheum Dis. 2022 Aug;81(8):e137. doi: 10.1136/annrheumdis-2020-218403. Epub 2020 Jul 31. Ann Rheum Dis. 2022. PMID: 32737110 No abstract available.

Abnormal liver tests in patients with SARS-CoV-2 or influenza - prognostic similarities and temporal disparities.

Shafran N, Issachar A, Shochat T, Shafran IH, Bursztyn M, Shlomai A. Shafran N, et al. Among authors: shafran ih. JHEP Rep. 2021 Jun;3(3):100258. doi: 10.1016/j.jhepr.2021.100258. Epub 2021 Feb 24. JHEP Rep. 2021. PMID: 33644724 Free PMC article.

Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab.

Shafran IH, Alasti F, Smolen JS, Aletaha D. Shafran IH, et al. Ann Rheum Dis. 2020 Jul;79(7):874-882. doi: 10.1136/annrheumdis-2019-215987. Epub 2020 May 5. Ann Rheum Dis. 2020. PMID: 32371387

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

3 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year